Etanercept in the treatment of rheumatoid arthritis: Clinical follow-up over one year by ultrasonography

Clinical Rheumatology

Volumn 27, Issue 4, 2008, Pages 491-496

  Iagnocco, Annamaria ^a   Perella, Chiara ^a   Naredo, Esperanza ^b   Meenagh, Gary ^c   Ceccarelli, Fulvia ^a   Tripodo, Emanuela ^a   Basili, Stefania ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c MUSGRAVE PARK HOSPITAL   (United Kingdom)

Author keywords

Etanercept; Follow up; Rheumatoid arthritis; Ultrasonography

Indexed keywords

C REACTIVE PROTEIN; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INDOMETACIN; METHOTREXATE; METHYLPREDNISOLONE; NIMESULIDE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BONE EROSION; BURSITIS; CHONDROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; INTERPHALANGEAL JOINT; JOINT SWELLING; KNEE; LABORATORY TEST; MALE; METACARPOPHALANGEAL JOINT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVITIS; TENOSYNOVITIS; TREATMENT DURATION; VISUAL ANALOG SCALE; WRIST;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; JOINTS; MALE; MIDDLE AGED; PAIN MEASUREMENT; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 40949142396     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0738-3     Document Type: Article

References (46)

1. Arnett FC, Keat ACS (1997) Spondyloarthropathies. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, St. Louis, pp 10.1-20.12
2. Macias I, Garcia-Perez S, Ruiz-Tudela M, Medina F, Chozas N, Giron-Gonzalez JA (2005) Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis. J Rheumatol 32:2102-2108
3. Feldmann M, Brennan FM, Foxwell BM, Maini RN (2001) The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 3:188-199
4. Taylor PC, Sivakumar B (2005) Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 17:293-298
5. Ritchlin CT (2004) Mechanisms of erosion in rheumatoid arthritis. J Rheumatol 31:1229-1237
6. Furst DE, Breedveld FC, Kalden JR, Smolen JS, Antoni CE, Bijlsma JWJ et al (2002) Updated consesus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases. Ann Rheum Dis 61(Suppl II):iI2-ii7
7. Bresnihan B (2002) Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis. Ann Rheum Dis 61(Suppl II):iI74-ii77
8. Maini RN, Taylor PC, Paleolog E (1999) Anti-tumor necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. Ann Rheum Dis 58(Suppl I):I156-II60
9. Kruithof E, Van den Bosch F, Baeten D, Herssens A, de Keyser F, Mielants H, Veys EM (2002) Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: One year follow up. Ann Rheum Dis 61:207-212
10. Van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C et al (2006) Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: The TEMPO trial. Ann Rheum Dis 65(3):328-334
11. Moreland L (2004) Etanercept and methotrexate combination in rheumatoid arthritis. Curr Rheumatol Rep 6(5):333
12. Wakefield RJ, Gibbon WW, Emery P (1999) The current status of ultrasonography in rheumatology. Rheumatology 38:195-198
13. Alarcon GS, Lopex-Ben R, Moreland LW (2002) High-resolution ultrasound for the study of target joints in rheumatoid arthritis. Arthritis Rheum 46:1969-1980
14. Newman JS, Laing TJ, McCarthy CJ, Adler RS (1996) Power Dopppler sonography of synovitis: Assessment of therapeutic response-preliminary observations. Radiology 198:582-584
15. Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F (2001) Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 44:331-338
16. Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, McGonagle D, Pease C et al (2000) The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: A comparison with conventional radiography. Arthritis Rheum 43:2762-2770
17. Backhaus M, Burmester G-R, Gerber T, Grassi W, Machold KP, Swen WA et al (2001) Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 60:641-649
18. Schmidt WA, Schmidt H, Schicke B, Gromnica-Ihle E (2004) Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis 63(8):988-994
19. Balint PV, Kane D, Wilson H (2002) Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61:905-910
20. Frediani B, Falsetti P, Storri L, Allegri A, Bisogno S, Baldi F et al (2002) Ultrasound and clinical evaluation of quadricipital tendon enthesitis in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol 21:203-206
21. Naranjo A, Marrero-Pulido T, Ojeda S, Francisco F, Erausquin C, Rua-Figueroa I et al (2002) Abnormal sonographic findings in the asymptomatic arthritic shoulder. Scand J Rheumatol 31(1):17-21
22. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA et al OMERACT 7 Special Interest Group (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32(12):2485-2487
23. Iagnocco A, Ossandon A, Coari G, Conti F, Priori R, Alessandri C et al (2004) Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol 22(5):621-624
24. Szkudlarek M, Court-Payen M, Strandberg C, Klarlund M, Klausen T, Østergaard M (2001) Power doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis. Arthritis Rheum 44(9):2018-2023
25. D'Agostino MA, Breban M, Said-Nahal R, Dougados M (2002) Refractory inflammatory heel pain in spondylarthropathy: A significant response to infliximab documented by ultrasound. Arthritis Rheum 46(3):840-841
26. Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, Bonnet V et al (2003) Rheumatoid hand joint synovitis: Gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. Radiology 229(2):562-569
27. Taylor PC, Steuer A, Gruber J, McClinton C, Cosgrove DO, Blomley MJ et al (2005) Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Arthritis Rheum 54(1):47-53
28. Hau M, Kneitz C, Tony HP, Keberle M, Jahans R, Jenett M (2002) High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis. Ann Rheum Dis 61:55-58
29. Terslev L, Torp-Pedersen S, Qvistgaard E, Kristoffersen H, Rogind H, Danneskiold-Samsoe B et al (2003) Effects of treatment with etanercept (Enbrel, TNRF:FC) on rheumatoid arthritis evaluated by Doppler ultrasonography. Ann Rheum Dis 62:178-181
30. Fiocco U, Ferro F, Vezzu M, Cozzi L, Checchetto C, Sfriso P et al (2005) Rheumatoid and psoriatic knee synovitis: Clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis 64(6):899-905
31. Cardinal E, Lafortune M, Burns P (1996) Power Doppler us in synovitis: reality or artifact? Radiology 200(3):868-869
32. Klauser A, Frauscher F, Schirmer M, Halpern E, Pallwein L, Herold M et al (2002) The value of contrast-enhanced color Doppler ultrasound in the detection of vascularization of finger joints in patients with rheumatoid arthritis. Arthritis Rheum 46(3):647-653
33. Klocke R, Glew D, Cox N, Blake DR (2001) Sonographic erosions of the rheumatoid little toe. Ann Rheum Dis 60:896-904
34. Magarelli N, Guglielmi G, Di Matteo L, Tartaro A, Mattei PA, Bonomo L (2001) Diagnostic utility of an echo-contrast agent in patients with synovitis using power Doppler ultrasound: A preliminary study with comparison to contrast-enhanced MRI. Eur Radiol 11:1039-1046
35. Stone M, Bergin D, Whelan B, Maher M, Murray J, McCarthy C (2001) Power Doppler ultrasound assessment of rheumatoid hand synovitis. J Rheumatol 28(9):1979-1982
36. St Clair EW (2002) Infliximab treatment for rheumatic disease: Clinical and radiological efficacy. Ann Rheum Dis 61(Suppl II):iI67-ii69
37. Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Biurbara CA et al (2003) Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial. Arthritis Rheum 48:35-45
38. Antoni C, Dechant C, Hanns-Martin Lorenz PD, Wendler J, Ogilvie A, Lueftl M et al (2002) Open-label study of infliximab treatment for psoriatic arthritis: Clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum 47(5):506-512
39. Braun J, Sieper J, Breban M, Collantes-Estevez E, Davis J, Inman R et al (2002) Anti-tumor necrosis factor α therapy for ankylosing spondylitis: International experience. Ann Rheum Dis 61(Suppl III):iIi51-iii60
40. Charles PJ, Smeenk RTJ, De Jong J, Feldmann M, Maini RN (2000) Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α. Arthritis Rheum 43(11):2383-2390
41. Garrison L, McDonnell ND (1999) Etanercept: Therapeutic use in patients with rheumatoid arthritis. Ann Rheum Dis 58(suppl I):I65-I69
42. Jones G, Halbert J, Crotty M, Shanahan EM, Batterham M, Ahern M (2003) The effect of treatment on radiological progression in rheumatoid arthritis: A systematic review of randomized placebo-controlled trials. Rheumatology 42:6-13
43. Rau R (2002) Adalimumab (a fully human anti-tumor necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: The initial results of five trials. Ann Rheum Dis 61(Suppl II):iI70-ii73
44. Sokka T, Pincus T (2003) Elegibility of patients in routine care for major clinical trials of anti-tumor necrosis factor α agents in rheumatoid arthritis. Arthritis Rheum 48:313-318
45. St Clair EW, Wagner CL, Fasanmade AA, Wang B, Schaible T, Kavanaugh A et al (2002) The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis. Arthritis Rheum 46:1451-1459
46. Ulfgren AK, Andersson U, Engstromm M, Klareskog L, Maini RN, Taylor PC (2000) Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis α synthesis. Arthritis Rheum 43:2391-2396